Shield Therapeutics (GB:STX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Shield Therapeutics is set to raise $10 million through a share subscription agreement with AOP Health, contingent on shareholder approval, which would grant AOP a controlling stake. Additionally, the company plans a RetailBook Offer to raise up to £1 million from existing retail shareholders. This financial maneuver is crucial for Shield’s goal of becoming cash flow positive by the end of 2025.
For further insights into GB:STX stock, check out TipRanks’ Stock Analysis page.
